Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
ASE Technology Holding Co., Ltd. American Depositary Shares (each representing
(NY:
ASX
)
9.180
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ASE Technology Holding Co., Ltd. American Depositary Shares (each representing
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress
May 07, 2025
ATH434 Phase 2 Data to be Presented at Opening Plenary Session
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy
May 05, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Appendix 4C – Q3 FY25 Quarterly Cash Flow Report
April 30, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Earnings Scheduled For April 30, 2025
April 30, 2025
Via
Benzinga
P/E Ratio Insights for ASE Technology Holding Co
April 29, 2025
Via
Benzinga
Earnings Scheduled For February 13, 2025
February 13, 2025
Via
Benzinga
Current Report ASE Technology
January 06, 2025
Share price rose about 19% in the past year from $8.59 to $10.21, as of Friday’s market close.
Via
Talk Markets
Topics
Stocks / Equities
Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium
April 28, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
ASE Technology Holding Co Honors Outstanding Suppliers of 2024
April 11, 2025
From
ASE Technology Holding Co., Ltd.
Via
Business Wire
Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting
April 10, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Alterity Therapeutics to Deliver an Oral Presentation of the Positive ATH434 Phase 2 Trial Results at the American Academy of Neurology Annual Meeting
April 03, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
ASE Demonstrates CPO that Improves Energy Efficiency for AI applications
April 01, 2025
From
Advanced Semiconductor Engineering, Inc.
Via
Business Wire
Alterity Therapeutics Completes Last Patient Visit in ATH434-202 Open-Label Phase 2 Trial in Multiple System Atrophy
March 27, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Oil & Gas Virtual Investor Conference Agenda Announced for March 27th
March 25, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Life360 Adds a Touch of Kawaii With Tile X Hello Kitty®, a Limited-Edition Collection in Partnership With Sanrio
March 20, 2025
Hello Kitty® Adds Her Supercute Charm to a Specially Designed Lineup of Bluetooth Trackers, Tile Mate and Tile Slim, Available Starting March 20
From
Life360, Inc.
Via
GlobeNewswire
Life360 Appoints Former Amazon Cybersecurity Lead Vari Bindra as Chief Information Security Officer
March 19, 2025
Newly-created role underscores company’s commitment to safeguarding the digital well-being of millions of families worldwide
From
Life360, Inc.
Via
GlobeNewswire
Baker Hughes and Woodside Energy Announce Collaboration Framework to Develop Small-Scale Decarbonization Solution Utilizing Net Power Platform
March 06, 2025
From
Baker Hughes
Via
GlobeNewswire
Esperion Partners with CSL Seqirus to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Australia
March 03, 2025
– Esperion to Receive an Upfront Payment and Near-Term Milestones Along with a Profitable Transfer Price on Product Sales –
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Life360 Reports Record Q4 and FY 2024 Results
February 27, 2025
From
Life360, Inc.
Via
GlobeNewswire
Life360 Enhances Advertising Capabilities with Strategic Acquisition of Fantix’s AdTech AI Platform
February 27, 2025
AI Data Science platform will empower smarter, targeted advertising solutions while preserving privacy
From
Life360, Inc.
Via
GlobeNewswire
ASE Technology Expands In Malaysia: New High-Tech Chip Facility Boosts Semiconductor Growth
February 18, 2025
ASE Technology Holding opens new chip packaging and testing facility in Penang, Malaysia, boosting the country's role in global semiconductor industry.
Via
Benzinga
ASE Expands its Chip Packaging and Testing Facility to Enable Next-Gen Applications
February 18, 2025
From
Advanced Semiconductor Engineering, Inc.
Via
Business Wire
Alterity Therapeutics Raises A$40.0 million in Placement
February 10, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing
February 07, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Life360 to Announce Q4 and Full Year 2024 Financial Results on February 27, 2025
January 31, 2025
From
Life360, Inc.
Via
GlobeNewswire
Dotz Nano to Present at the Small Cap Growth Virtual Investor Conference February 6th
January 30, 2025
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Alterity Therapeutics Announces Positive ATH434 Phase 2 Trial Results in Multiple System Atrophy Led By Robust Clinical Efficacy
January 30, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Trump Says Its Time For US To 'Return' To A System That Made It Rich And Powerful As The President Proposes Tariffs On Taiwan: 'Bring Production Back To Our Country'
January 28, 2025
President Donald Trump's pledge to impose sweeping tariffs on imports from Taiwan is raising concerns across semiconductor and pharmaceutical industries, particularly affecting Taiwan Semiconductor...
Via
Benzinga
Topics
Government
World Trade
Exposures
Political
Tariff
Appendix 4C – Q2 FY25 Quarterly Cash Flow Report
January 24, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
January 09, 2025
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.